{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:22:42Z","timestamp":1790227362890,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Ricerca Corrente"],"award-info":[{"award-number":["Ricerca Corrente"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-31838-w","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T04:16:53Z","timestamp":1765340213000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Immune profiling identifies the contribution of extracellular vesicles to immune modulation and progression in prostate cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Giovanni","family":"Pecoraro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginevra","family":"Sarnacchiaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Smaldone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Soricelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"31838_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"Cancer J. Clin."},{"key":"31838_CR2","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay, J. et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136, E359\u2013E386 (2015).","journal-title":"Int. J. Cancer"},{"key":"31838_CR3","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a030411","volume":"7","author":"PA Humphrey","year":"2017","unstructured":"Humphrey, P. A. Histopathology of Prostate Cancer. Cold Spring. Harb. Perspect. Med. 7, a030411 (2017).","journal-title":"Cold Spring. Harb. Perspect. Med."},{"key":"31838_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12894-022-01135-z","volume":"22","author":"C Sun","year":"2022","unstructured":"Sun, C. et al. Modified the 8th AJCC staging system for patients with advanced prostate cancer: a study based on SEER database. BMC Urol. 22, 185 (2022).","journal-title":"BMC Urol."},{"key":"31838_CR5","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41585-022-00638-6","volume":"19","author":"H Van Poppel","year":"2022","unstructured":"Van Poppel, H. et al. Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future. Nat. Rev. Urol. 19, 562\u2013572 (2022).","journal-title":"Nat. Rev. Urol."},{"key":"31838_CR6","doi-asserted-by":"publisher","first-page":"2279235","DOI":"10.1080\/07853890.2023.2279235","volume":"55","author":"Q Ge","year":"2023","unstructured":"Ge, Q. et al. Molecular classifications of prostate cancer: basis for individualized risk stratification and precision therapy. Ann. Med. 55, 2279235 (2023).","journal-title":"Ann. Med."},{"key":"31838_CR7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.eururo.2022.11.002","volume":"83","author":"S Gillessen","year":"2023","unstructured":"Gillessen, S. et al. Management of patients with advanced prostate cancer. Part I: intermediate-\/high-risk and locally advanced disease, biochemical relapse, and side effects of hormonal treatment: report of the advanced prostate cancer consensus conference 2022. Eur. Urol. 83, 267\u2013293 (2023).","journal-title":"Eur. Urol."},{"key":"31838_CR8","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S0140-6736(21)00950-8","volume":"398","author":"S Sandhu","year":"2021","unstructured":"Sandhu, S. et al. Prostate cancer. Lancet 398, 1075\u20131090 (2021).","journal-title":"Lancet"},{"key":"31838_CR9","first-page":"115","volume":"37","author":"JS Horoszewicz","year":"1980","unstructured":"Horoszewicz, J. S. et al. The LNCaP cell line\u2013a new model for studies on human prostatic carcinoma. Prog. Clin. Biol. Res. 37, 115\u2013132 (1980).","journal-title":"Prog. Clin. Biol. Res."},{"key":"31838_CR10","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/ijc.2910210305","volume":"21","author":"KR Stone","year":"1978","unstructured":"Stone, K. R., Mickey, D. D., Wunderli, H., Mickey, G. H. & Paulson, D. F. Isolation of a human prostate carcinoma cell line (DU 145). Int. J. Cancer 21, 274\u2013281 (1978).","journal-title":"Int. J. Cancer"},{"key":"31838_CR11","first-page":"16","volume":"17","author":"ME Kaighn","year":"1979","unstructured":"Kaighn, M. E., Narayan, K. S., Ohnuki, Y., Lechner, J. F. & Jones, L. W. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest. Urol. 17, 16\u201323 (1979).","journal-title":"Invest. Urol."},{"key":"31838_CR12","doi-asserted-by":"publisher","first-page":"932510","DOI":"10.3389\/fcell.2022.932510","volume":"10","author":"CW Molter","year":"2022","unstructured":"Molter, C. W. et al. Prostate cancer cells of increasing metastatic potential exhibit diverse contractile forces, cell stiffness, and motility in a microenvironment stiffness-dependent manner. Front. Cell Dev. Biol. 10, 932510 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"31838_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3390\/cells8010074","volume":"8","author":"T Namekawa","year":"2019","unstructured":"Namekawa, T., Ikeda, K., Horie-Inoue, K. & Inoue, S. Application of prostate cancer models for preclinical study: advantages and limitations of cell lines, patient-derived Xenografts, and three-dimensional culture of patient-derived cells. Cells 8, 74 (2019).","journal-title":"Cells"},{"key":"31838_CR14","first-page":"3522","volume":"44","author":"JM Kozlowski","year":"1984","unstructured":"Kozlowski, J. M. et al. Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res. 44, 3522\u20133529 (1984).","journal-title":"Cancer Res."},{"key":"31838_CR15","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","volume":"79","author":"DC Hinshaw","year":"2019","unstructured":"Hinshaw, D. C. & Shevde, L. A. The Tumor Microenvironment Innately Modulates Cancer Progression. Cancer Res. 79, 4557\u20134566 (2019).","journal-title":"Cancer Res."},{"key":"31838_CR16","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1038\/s41379-018-0083-x","volume":"31","author":"HB Kaur","year":"2018","unstructured":"Kaur, H. B. et al. Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer. Mod. Pathol. 31, 1539\u20131552 (2018).","journal-title":"Mod. Pathol."},{"key":"31838_CR17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.euf.2017.05.013","volume":"5","author":"F Petitprez","year":"2019","unstructured":"Petitprez, F. et al. PD-L1 Expression and CD8+ T-cell Infiltrate are Associated with Clinical Progression in Patients with Node-positive Prostate Cancer. Eur. Urol. Focus 5, 192\u2013196 (2019).","journal-title":"Eur. Urol. Focus"},{"key":"31838_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1479-5876-12-30","volume":"12","author":"JR Woo","year":"2014","unstructured":"Woo, J. R. et al. Tumor infiltrating B-cells are increased in prostate cancer tissue. J. Transl. Med. 12, 30 (2014).","journal-title":"J. Transl. Med."},{"key":"31838_CR19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nature08782","volume":"464","author":"M Ammirante","year":"2010","unstructured":"Ammirante, M., Luo, J.-L., Grivennikov, S., Nedospasov, S. & Karin, M. B-cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature 464, 302\u2013305 (2010).","journal-title":"Nature"},{"key":"31838_CR20","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1158\/2326-6066.CIR-19-0115","volume":"7","author":"A Teijeira","year":"2019","unstructured":"Teijeira, A. et al. Metabolic Consequences of T-cell Costimulation in Anticancer Immunity. Cancer Immunol. Res. 7, 1564\u20131569 (2019).","journal-title":"Cancer Immunol. Res."},{"key":"31838_CR21","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/nature21676","volume":"543","author":"X Lu","year":"2017","unstructured":"Lu, X. et al. Effective combinatorial immunotherapy for castration-resistant prostate cancer. Nature 543, 728\u2013732 (2017).","journal-title":"Nature"},{"key":"31838_CR22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s12935-023-03123-1","volume":"23","author":"A Altuna-Coy","year":"2023","unstructured":"Altuna-Coy, A., Ruiz-Plazas, X., Arreaza-Gil, V., Segarra-Tom\u00e1s, J. & Chac\u00f3n, M. R. In silico analysis of prognostic and diagnostic significance of target genes from prostate cancer cell lines derived exomicroRNAs. Cancer Cell Int. 23, 275 (2023).","journal-title":"Cancer Cell Int."},{"key":"31838_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1194\/jlr.R084343","volume":"60","author":"T Skotland","year":"2019","unstructured":"Skotland, T., Hessvik, N. P., Sandvig, K. & Llorente, A. Exosomal lipid composition and the role of ether lipids and phosphoinositides in exosome biology. J. Lipid Res. 60, 9\u201318 (2019).","journal-title":"J. Lipid Res."},{"key":"31838_CR24","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654\u2013659 (2007).","journal-title":"Nat. Cell Biol."},{"key":"31838_CR25","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00018-016-2346-3","volume":"74","author":"Y Naito","year":"2017","unstructured":"Naito, Y., Yoshioka, Y., Yamamoto, Y. & Ochiya, T. How cancer cells dictate their microenvironment: present roles of extracellular vesicles. Cell Mol. Life Sci. 74, 697\u2013713 (2017).","journal-title":"Cell Mol. Life Sci."},{"key":"31838_CR26","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/mc.22124","volume":"54","author":"A Ramteke","year":"2015","unstructured":"Ramteke, A. et al. Exosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction molecules. Mol. Carcinog. 54, 554\u2013565 (2015).","journal-title":"Mol. Carcinog."},{"key":"31838_CR27","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/mc.23157","volume":"59","author":"G Deep","year":"2020","unstructured":"Deep, G. et al. Exosomes secreted by prostate cancer cells under hypoxia promote matrix metalloproteinases activity at pre-metastatic niches. Mol. Carcinog. 59, 323\u2013332 (2020).","journal-title":"Mol. Carcinog."},{"key":"31838_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12943-019-0995-1","volume":"18","author":"Y Guo","year":"2019","unstructured":"Guo, Y. et al. Effects of exosomes on pre-metastatic niche formation in tumors. Mol. Cancer 18, 39 (2019).","journal-title":"Mol. Cancer"},{"key":"31838_CR29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12943-019-0975-5","volume":"18","author":"I Li","year":"2019","unstructured":"Li, I. & Nabet, B. Y. Exosomes in the tumor microenvironment as mediators of cancer therapy resistance. Mol. Cancer 18, 32 (2019).","journal-title":"Mol. Cancer"},{"key":"31838_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12943-019-0991-5","volume":"18","author":"L Mashouri","year":"2019","unstructured":"Mashouri, L. et al. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Mol. Cancer 18, 75 (2019).","journal-title":"Mol. Cancer"},{"key":"31838_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh, J. A. et al. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J. Extracell. Vesicles 13, e12404 (2024).","journal-title":"J. Extracell. Vesicles"},{"key":"31838_CR32","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser, K. E. & Joyce, J. A. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell 41, 374\u2013403 (2023).","journal-title":"Cancer Cell"},{"key":"31838_CR33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12964-020-00643-5","volume":"18","author":"S-C Tao","year":"2020","unstructured":"Tao, S.-C. & Guo, S.-C. Role of extracellular vesicles in tumour microenvironment. Cell Commun. Signal. 18, 163 (2020).","journal-title":"Cell Commun. Signal."},{"key":"31838_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-024-01735-1","volume":"9","author":"MA Kumar","year":"2024","unstructured":"Kumar, M. A. et al. Extracellular vesicles as tools and targets in therapy for diseases. Sig. Transduct. Target Ther. 9, 1\u201341 (2024).","journal-title":"Sig. Transduct. Target Ther."},{"key":"31838_CR35","doi-asserted-by":"publisher","first-page":"1045624","DOI":"10.3389\/fimmu.2022.1045624","volume":"13","author":"S Wang","year":"2022","unstructured":"Wang, S., Sun, J., Dastgheyb, R. M. & Li, Z. Tumor-derived extracellular vesicles modulate innate immune responses to affect tumor progression. Front. Immunol. 13, 1045624 (2022).","journal-title":"Front. Immunol."},{"key":"31838_CR36","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.semcancer.2021.09.004","volume":"86","author":"E Vergani","year":"2022","unstructured":"Vergani, E. et al. Extracellular vesicles in anti-tumor immunity. Semin. Cancer Biol. 86, 64\u201379 (2022).","journal-title":"Semin. Cancer Biol."},{"key":"31838_CR37","doi-asserted-by":"publisher","first-page":"6892","DOI":"10.3390\/jcm11236892","volume":"11","author":"A Reale","year":"2022","unstructured":"Reale, A., Khong, T. & Spencer, A. Extracellular vesicles and their roles in the tumor immune microenvironment. J. Clin. Med. 11, 6892 (2022).","journal-title":"J. Clin. Med."},{"key":"31838_CR38","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.3390\/cancers12123563","volume":"12","author":"S Mittal","year":"2020","unstructured":"Mittal, S., Gupta, P., Chaluvally-Raghavan, P. & Pradeep, S. Emerging role of extracellular vesicles in immune regulation and cancer progression. Cancers (Basel) 12, 3563 (2020).","journal-title":"Cancers (Basel)"},{"key":"31838_CR39","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.exphem.2004.05.027","volume":"32","author":"A Szaflarska","year":"2004","unstructured":"Szaflarska, A. et al. Antitumor response of CD14+\/CD16+ monocyte subpopulation. Exp. Hematol. 32, 748\u2013755 (2004).","journal-title":"Exp. Hematol."},{"key":"31838_CR40","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1189\/jlb.0806510","volume":"81","author":"L Ziegler-Heitbrock","year":"2007","unstructured":"Ziegler-Heitbrock, L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J. Leukoc Biol. 81, 584\u2013592 (2007).","journal-title":"J. Leukoc Biol."},{"key":"31838_CR41","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1159\/000541881","volume":"103","author":"R Novysedlak","year":"2024","unstructured":"Novysedlak, R. et al. The immune microenvironment in prostate cancer: a comprehensive review. Oncology 103, 521\u2013545 (2024).","journal-title":"Oncology"},{"key":"31838_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1475-2867-6-10","volume":"6","author":"L Huang","year":"2006","unstructured":"Huang, L., Kirschke, C. P. & Zhang, Y. Decreased intracellular zinc in human tumorigenic prostate epithelial cells: a possible role in prostate cancer progression. Cancer Cell Int. 6, 10 (2006).","journal-title":"Cancer Cell Int."},{"key":"31838_CR43","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/pcan.2014.17","volume":"17","author":"P Sargos","year":"2014","unstructured":"Sargos, P. et al. Characterization of prostate neuroendocrine cancers and therapeutic management: a literature review. Prostate Cancer Prostatic Dis. 17, 220\u2013226 (2014).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"31838_CR44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1677\/erc.1.01043","volume":"13","author":"T-C Yuan","year":"2006","unstructured":"Yuan, T.-C. et al. Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells. Endocr. Relat. Cancer 13, 151\u2013167 (2006).","journal-title":"Endocr. Relat. Cancer"},{"key":"31838_CR45","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-22-0211","author":"L Brady","year":"2023","unstructured":"Brady, L. & Nelson, P. S. RISING STARS: Heterogeneity and the tumor microenvironment in neuroendocrine prostate cancer. J. Endocrinol. https:\/\/doi.org\/10.1530\/JOE-22-0211 (2023).","journal-title":"J. Endocrinol."},{"key":"31838_CR46","doi-asserted-by":"publisher","first-page":"8955","DOI":"10.3390\/ijms24108955","volume":"24","author":"R Watanabe","year":"2023","unstructured":"Watanabe, R. et al. Spatial Gene Expression Analysis Reveals Characteristic Gene Expression Patterns of De Novo Neuroendocrine Prostate Cancer Coexisting with Androgen Receptor Pathway Prostate Cancer. Int. J. Mol. Sci. 24, 8955 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"31838_CR47","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1038\/s41598-025-88033-0","volume":"15","author":"E Mitsui","year":"2025","unstructured":"Mitsui, E. et al. Novel treatment strategy targeting interleukin-6 induced by cancer associated fibroblasts for peritoneal metastasis of gastric cancer. Sci. Rep. 15, 3267 (2025).","journal-title":"Sci. Rep."},{"key":"31838_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-021-00658-5","volume":"6","author":"H Zhao","year":"2021","unstructured":"Zhao, H. et al. Inflammation and tumor progression: signaling pathways and targeted intervention. Sig. Transduct Target Ther. 6, 1\u201346 (2021).","journal-title":"Sig. Transduct Target Ther."},{"key":"31838_CR49","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.canlet.2020.05.005","volume":"484","author":"S Galland","year":"2020","unstructured":"Galland, S., Martin, P., Fregni, G., Letovanec, I. & Stamenkovic, I. Attenuation of the pro-inflammatory signature of lung cancer-derived mesenchymal stromal cells by statins. Cancer Lett. 484, 50\u201364 (2020).","journal-title":"Cancer Lett."},{"key":"31838_CR50","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41568-023-00635-w","volume":"24","author":"TR Mempel","year":"2024","unstructured":"Mempel, T. R., Lill, J. K. & Altenburger, L. M. How chemokines organize the tumour microenvironment. Nat. Rev. Cancer 24, 28\u201350 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"31838_CR51","doi-asserted-by":"publisher","first-page":"1161067","DOI":"10.3389\/fimmu.2023.1161067","volume":"14","author":"V Carlini","year":"2023","unstructured":"Carlini, V. et al. The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions. Front. Immunol. 14, 1161067 (2023).","journal-title":"Front. Immunol."},{"key":"31838_CR52","doi-asserted-by":"publisher","first-page":"6104054","DOI":"10.1155\/2017\/6104054","volume":"2017","author":"JM Rojas","year":"2017","unstructured":"Rojas, J. M., Avia, M., Mart\u00edn, V. & Sevilla, N. IL-10: A Multifunctional Cytokine in Viral Infections. J. Immunol. Res. 2017, 6104054 (2017).","journal-title":"J. Immunol. Res."},{"key":"31838_CR53","doi-asserted-by":"publisher","first-page":"963","DOI":"10.21873\/anticanres.11405","volume":"37","author":"J Lin","year":"2017","unstructured":"Lin, J. et al. The role of IL-7 in Immunity and Cancer. Anticancer Res. 37, 963\u2013967 (2017).","journal-title":"Anticancer Res."},{"key":"31838_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2021.155479","volume":"142","author":"K Ioannis","year":"2021","unstructured":"Ioannis, K., Eralda, S., Egal, E. S. A. & Beswick, E. G-CSF in tumors: aggressiveness, tumor microenvironment and immune cell regulation. Cytokine 142, 155479 (2021).","journal-title":"Cytokine"},{"key":"31838_CR55","doi-asserted-by":"publisher","first-page":"1502405","DOI":"10.3389\/fonc.2025.1502405","volume":"15","author":"G Pecoraro","year":"2025","unstructured":"Pecoraro, G. et al. Co-modulation of a circular form of PCDH11Y during neuroendocrine differentiation of prostate cancer. Front. Oncol. 15, 1502405 (2025).","journal-title":"Front. Oncol."},{"key":"31838_CR56","doi-asserted-by":"publisher","first-page":"5864","DOI":"10.3390\/ijms25115864","volume":"25","author":"I Leone","year":"2024","unstructured":"Leone, I. et al. Triple-Negative Breast Cancer EVs Modulate Growth and Migration of Normal Epithelial Lung Cells. Int. J. Mol. Sci. 25, 5864 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"31838_CR57","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.3390\/biology12121531","volume":"12","author":"J Santoro","year":"2023","unstructured":"Santoro, J. et al. Influence of Breast Cancer Extracellular Vesicles on Immune Cell Activation: A Pilot Study. Biology 12, 1531 (2023).","journal-title":"Biology"},{"key":"31838_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0235214","volume":"15","author":"H Zhang","year":"2020","unstructured":"Zhang, H., Silva, A. C., Zhang, W., Rutigliano, H. & Zhou, A. Raman Spectroscopy characterization extracellular vesicles from bovine placenta and peripheral blood mononuclear cells. PLoS ONE 15, e0235214 (2020).","journal-title":"PLoS ONE"},{"key":"31838_CR59","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nmeth.4185","volume":"14","author":"J Van Deun","year":"2017","unstructured":"Van Deun, J. et al. EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research. Nat. Methods 14, 228\u2013232 (2017).","journal-title":"Nat. Methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31838-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31838-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31838-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T14:03:35Z","timestamp":1768485815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31838-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["31838"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-31838-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2112"}}